Synthesis and In Vivo Immunological Evaluation of Novel Saponin–Antigen Conjugates Incorporating Tumor‐Associated Carbohydrate and Peptide Epitopes
Chemistry – A European Journal · 2026
DOI: 10.1002/chem.71192 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, 2026. Verfasst von Roberto Fuentes und 3 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Immunology Laboratory, Center for Cooperative Research in Biosciences (CIC Biogune), Basque Research and Technology alliance (BRTA), Derio, …. Hauptthemen laut MEDLINE: Saponins, Antigens, Tumor-Associated, Carbohydrate, Cancer Vaccines, Epitopes. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Spanish Research Agency, Spanish Association against Cancer, European Research Council.
Abstract (Originalsprache)
Subunit cancer vaccines based on aberrant glyglycoproteins or glycolipids overexpressed on the tumor cell surface are limited by the inherent low immunogenicity of the corresponding glycan/peptide antigens. As such, they require the implementation of novel strategies that can boost the induced immune responses. One of these approaches exploits the conjugation of such antigenic fragments to immunoactive molecules, such as adjuvants and immunostimulatory epitopes, leading to unimolecular constructs with self‐adjuvanting properties. Herein, we report the development of novel di‐ and tricomponent conjugates built upon a streamlined, underexploited saponin scaffold derived from the QS‐21 adjuvant, which was covalently linked to carbohydrate and peptide antigens found on tumor‐associated glycolipids (e.g., Gb3 trisaccharide) and glycoproteins (e.g., Tn antigen and MUC1 tandem repeat sequence). Facile, late‐stage conjugation to a T‐helper peptide epitope resulted in self‐adjuvanting vaccine constructs that induced increased levels of antigen‐specific antibodies in mice recognizing the native antigen on cancer cells. The chemical versatility of our synthetically accessible saponin platform, together with the nontoxicity and immunogenicity of these new tricomponent candidates, emphasizes the potential of our novel saponin‐based, self‐adjuvanting approach for the development of molecular vaccine prototypes with prospective applications in cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemical Immunology Laboratory, Center for Cooperative Research in Biosciences (CIC Biogune), Basque Research and Technology alliance (BRTA), Derio, Spain.
- Ikerbasque, Basque Foundation for Science, Bilbao, Spain.
ORCID-Profile: Roberto Fuentes, Priscila Tonon-Baschirotto, Leire Aguinagalde, Alberto Fernández-Tejada
Förderung
- Spanish Research Agency
- Spanish Association against Cancer
- European Research Council
Zitieren
APA
Fuentes, R., Tonon-Baschirotto, P., Aguinagalde, L., & Fernández-Tejada, A. (2026). Synthesis and In Vivo Immunological Evaluation of Novel Saponin–Antigen Conjugates Incorporating Tumor‐Associated Carbohydrate and Peptide Epitopes. Chemistry – A European Journal. https://doi.org/10.1002/chem.71192
Vancouver
Fuentes R, Tonon-Baschirotto P, Aguinagalde L, Fernández-Tejada A. Synthesis and In Vivo Immunological Evaluation of Novel Saponin–Antigen Conjugates Incorporating Tumor‐Associated Carbohydrate and Peptide Epitopes. Chemistry – A European Journal. 2026. doi:10.1002/chem.71192
BibTeX
@article{Fuentes2026,
author = {Fuentes, Roberto and Tonon-Baschirotto, Priscila and Aguinagalde, Leire and Fernández-Tejada, Alberto},
title = {Synthesis and In Vivo Immunological Evaluation of Novel Saponin–Antigen Conjugates Incorporating Tumor‐Associated Carbohydrate and Peptide Epitopes},
journal = {Chemistry – A European Journal},
year = {2026},
doi = {10.1002/chem.71192}
}
EUVIMED